African plant root, Paullinia pinnata, may be the answer to MRSA

NewsGuard 100/100 Score

A plant root used in Africa as a traditional remedy could hold the key to combating the potentially fatal Methicillin-Resistant Staphylococcus Aureus (MRSA) infection, according to research findings presented today at the British Pharmaceutical Conference in Manchester.

Pharmacists at King's College London have discovered that the roots of the shrub Paullinia pinnata possess anti-bacterial properties that are effective against MRSA.

MRSA infections are difficult to combat because the bacteria involved have developed complete resistance to certain antibiotics. Usually it is hospital patients with weakened immune systems who are most likely to become infected.

The Paullinia pinnata root has been traditionally used in the treatment of wounds in rural populations in Ghana, and is now being used widely in cities.

The research team tested extracts in the root of the Paullinia pinnata plant on wounds in rats. They found the extracts to be anti-bacterial and effective against certain strains of MRSA. In addition, the extracts were found to work as an antioxidant, which helps in the healing process by boosting the immune system and helping the growth of new cells.

Pharmacist Kofi Annan, member of the Pharmacognosy Research Group at the Department of Pharmacy, King's College London said that the results were "fantastic".

"This plant has never been researched scientifically," he explains. "We were surprised and excited by the results and think that the Paullinia pinnata root could hold the key to the future treatment of MRSA."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research confirms no association between SARS-CoV-2 and childhood asthma diagnoses